HY Capital is a venture capital firm established in 2015 and based in Shanghai, China. The firm focuses on the healthcare industry, specializing in early-stage and growth-stage investments. By targeting innovative companies within the healthcare sector, HY Capital aims to support the development of new technologies and solutions that can improve patient care and health outcomes.
Only Sanbio is a synthetic biotechnology company integrating R&D, production, and sales. Itsmed vision is to focus on the field of great health and great beauty, based on synthetic biology technology
Linyan Medical
Venture Round in 2025
Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Kang Ruijian
Seed Round in 2025
Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
Onico Medical
Seed Round in 2025
Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
Sylvanus Gene
Angel Round in 2023
Sylvanus Gene is a gene technology company that focuses on R&D and the production of molecular diagnostic equipment for pathogenic microorganisms.
Biotyx Medical
Series B in 2023
Biotyx Medical specializes in the development and manufacturing of iron-based biodegradable vascular materials and stents. The company focuses on creating bioabsorbable vascular scaffolds that are designed to provide safe and effective treatment options for patients. By offering these innovative products at affordable prices, Biotyx Medical aims to support healthcare professionals in delivering quality care while addressing the challenges associated with traditional vascular materials.
Puncture Robotic
Series A in 2023
Puncture Robotic specializes in the development of venipuncture robots that automate the process of blood collection, eliminating the need for human intervention. The company focuses on providing intelligent and automated solutions tailored for medical institutions. Its robots utilize real-time image navigation technology for soft tissue interventions, which are beneficial in various applications including percutaneous puncture procedures related to thoracoabdominal and pelvic tumors, as well as in the field of medical aesthetics. By offering cost-effective robotic solutions, Puncture Robotic aims to enhance operational efficiency and improve patient care in hospitals and healthcare organizations.
Chinagene Tech
Series A in 2022
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Juncell Therapeutics
Series A in 2022
Juncell Therapeutics focuses on developing innovative therapies and pharmaceutical drugs specifically for tumor treatment. The company specializes in tumor cell therapy, offering solutions to isolate tumor-infiltrating lymphocytes (TILs) from tumor tissues. These TILs are subsequently developed outside the human body and re-injected into patients, allowing for targeted treatment of tumors. This approach aims to enhance the effectiveness of cancer therapies while minimizing side effects, ultimately improving patient outcomes in the fight against cancer.
Yijian Health
Seed Round in 2022
Yijian Health is a precision medicine service platform that offers a range of genetic testing services and laboratory information management system (LIMS) software. The company focuses on gene sequencing to provide personalized medication guidance for various health conditions, including tumors, infections, and chronic diseases, as well as specialized services for women and children. By making advanced health care accessible, Yijian Health aims to deliver scientific and professional testing services to the general public, enhancing individualized treatment options.
ChosenMed
Series B in 2020
ChosenMed is a healthcare company specializing in oncology precision medicine. It is dedicated to early tumor screening and companion diagnosis, aiming to improve patient outcomes in cancer care. The company develops products that address the early screening, prevention, and diagnosis of tumors. Additionally, ChosenMed provides guidance for targeted medication related to solid tumors and predicts the efficacy of tumor immunotherapy. By offering a comprehensive range of precision medical solutions and immunotherapy options, ChosenMed strives to enhance treatment effectiveness and support personalized patient care in oncology.
Zhizu Tech
Series A in 2019
Zhizu Tech, officially known as Shanghai Zhizu Logistics Technology Co., Ltd., is a Shanghai-based company founded in 2018 that specializes in developing software and services for end-to-end distribution lease providers. The company offers solutions tailored for express delivery firms and food ordering platforms, enabling them to plan and manage their distribution fleets effectively. Its offerings include delivery vehicle rental services, smart battery swaps, and an IoT cloud management platform. Additionally, Zhizu Tech provides offline maintenance services and builds AI-based data systems to enhance vehicle connectivity. By focusing on logistics and delivery, the company aims to streamline operations and improve efficiency in the instant delivery sector.
MFA
Series A in 2019
MFA members say that it is a skin care platform that aims to make more and better skin care products go from the laboratory to the consumer market, so that more people can enjoy the life change caused by skin care.MFA members said that it is a membership-based beauty and e-commerce platform. It is committed to creating a platform model featuring annual membership e-commerce, relying on its own perfect supply chain advantages to create a “closed eye to buy for the public, big-name quality is not expensive. The shopping experience has been recognized by the consumer market and has a wide growing space.
Cloudbreak Therapeutics
Series A in 2018
Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.
Fushoukang
Series A in 2018
Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.
Fushoukang
Angel Round in 2018
Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.
Laviana Pharma
Series B in 2018
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.
Symbow Medical
Series A in 2017
Symbow Medical Technology specializes in the manufacturing and distribution of innovative medical devices aimed at tumor early diagnosis and minimally invasive treatment. The company offers a range of advanced equipment, including breast imaging systems and MRI and CT guided therapy platforms that utilize optical and electromagnetic tracking techniques. Among its notable products is the OPTIMUS dual-modality molecular imaging system, designed to enhance surgical planning and diagnosis through cutting-edge imaging solutions. Symbow Medical distributes its products through various channels in China and internationally, focusing on improving healthcare outcomes for patients and physicians alike.
UEG Medical
Series A in 2017
UEG Medical produces and sells medical devices to cover dental CT, surgical navigation systems, wound healing material, and disposable trocar. Their products such as accunavi-a surgical navigation system, surgical, implant guide, spectrum xl/l, bioactive glass, material for wound healing, disposable trocar, and clip applier.
Shudouzhe
Seed Round in 2016
Shudouzhe is a tool used by business owners to deal with tax and financial issues. Its goal is to assist business owners in resolving fiscal and tax issues. They are dedicated to assisting freelancers and business owners or offering innovative online financial and tax services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.